MEGAN BLEVINS: Open Payments
NPI 1376087064 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,353 in 78 payments from 21 companies in 2025. Trend: 2023 $1,761 · 2024 $1,549 · 2025 $2,353
Food & beverage: $2,346Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $499 |
| ABBVIE INC. | 9 | $375 |
| Axsome Therapeutics, Inc. | 3 | $224 |
| Supernus Pharmaceuticals, Inc. | 6 | $196 |
| Vanda Pharmaceuticals Inc. | 9 | $158 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $144 |
| Alkermes, Inc. | 5 | $122 |
| Lundbeck LLC | 4 | $105 |
| Biogen, Inc. | 1 | $102 |
| Neurocrine BioSciences, Inc. | 3 | $70 |
Products named: CAPLYTA, VRAYLAR, Auvelity, Qelbree, FANAPT, ZURZUVAE, TRINTELLIX, REXULTI.
Industry payments across FL — which companies pay providers there.
